Loyalty Program Comparison: Allē vs Aspire vs Evolus Rewards

Allē is AbbVie's digital loyalty platform for Botox, Juvéderm, Volbella, and related products. Members earn points on purchases; points convert to rebates or account credits. The program typically offers tiered earning: higher purchase volumes unlock better per-unit rebate rates. Allē also bundles non-injectable products (skincare, devices) and integrates patient-facing rewards (patient loyalty points that practices can use to drive retention). The program is free to join and does not require minimum purchase commitments, though rebate rates scale with volume. Key operational detail: Allē requires practice registration and integration with your ordering system or manual claim submission. Rebates are typically processed quarterly or upon claim. The platform also offers data analytics on your purchase patterns and patient demographics, which can inform inventory and marketing decisions.

Aspire is Galderma's loyalty program for Restylane, Dysport, and Radiesse. The program uses a tiered structure: practices commit to annual purchase volume targets (e.g., $50K, $100K, $250K) and receive corresponding rebate percentages. Higher tiers unlock better rates. Aspire also offers co-marketing support, training credits, and exclusive access to new product launches. Unlike Allē, Aspire typically requires a formal enrollment and may include volume commitments or minimum quarterly purchases to maintain tier status. Rebates are usually processed monthly or quarterly. Galderma has been aggressive in recruiting practices away from competitors, often offering sign-up bonuses or temporary rate enhancements. The program is particularly valuable if your practice has high Dysport or Restylane volume; the rebate structure rewards consolidation.

Evolus Rewards covers Jeuveau (prabotulinumtoxinA) and Evolus filler products. The program is simpler than Allē or Aspire: it offers a straightforward per-unit rebate on Jeuveau purchases (typically $1–$3 per unit, depending on volume tier) and per-syringe rebates on fillers. Evolus Rewards does not require formal enrollment or volume commitments; rebates accrue automatically on purchases. The program is designed to be low-friction and accessible to smaller practices or those testing Jeuveau adoption. Rebates are processed monthly. Because Jeuveau has smaller market share than Botox or Dysport, Evolus Rewards is most valuable for practices already committed to Jeuveau or looking to diversify toxin suppliers. The rebate rates are generally lower in absolute dollars than Allē or Aspire, but the lack of volume thresholds makes it predictable for smaller practices.

Stacking across programs is generally prohibited. You cannot enroll in Allē and Aspire simultaneously for overlapping products (e.g., you cannot claim rebates on the same Botox unit from both programs). However, practices can use different programs for different product lines: for example, Allē for Botox and Juvéderm, and Aspire for Dysport and Restylane. This is permissible because the products are distinct and the rebates do not overlap. Evolus Rewards can typically be stacked with Allē or Aspire if you are purchasing Jeuveau or Evolus-branded fillers (non-competing products). Always verify current stacking rules with each program, as policies evolve. From a compliance perspective, loyalty rebates are legal and do not violate Anti-Kickback Statute (AKS) rules if they are bona fide volume discounts offered uniformly to all eligible customers. However, document your enrollment, volume thresholds, and rebate calculations; auditors (including state boards and Medicare) may scrutinize them. Do not accept rebates contingent on patient referrals or tied to specific patient outcomes.

To compare programs, calculate the net cost per unit after rebates. Example: if you purchase 1,000 Botox units annually at $10/unit wholesale = $10,000 spend. Allē offers a 5% rebate at your volume tier = $500 annual rebate, or $0.50/unit. Aspire offers a 6% rebate = $600, or $0.60/unit. The $100 difference is modest but compounds. However, factor in non-rebate benefits: Allē's patient loyalty integration may drive higher patient lifetime value; Aspire's co-marketing support may reduce your marketing spend. Also consider switching costs: moving from one program to another may disrupt your ordering workflow or require renegotiating terms with your supplier. For practices with $150K+ annual injectable spend, the rebate difference between programs can equal $3K–$8K annually. For smaller practices, the operational simplicity of Evolus Rewards or the marketing support of Aspire may outweigh a 1% rebate difference.

Choose based on your product mix and volume profile. If your practice is heavily Botox and Juvéderm–focused (AbbVie products), Allē is the natural choice and offers the deepest integration with AbbVie's ecosystem. If you use Dysport or Restylane as primary products, Aspire delivers better value and Galderma's support infrastructure. If you are diversifying toxin suppliers or testing Jeuveau, Evolus Rewards offers low-friction entry. Multi-location practices should consider whether to standardize on one program across locations (simpler accounting, better volume leverage) or allow location-level autonomy (may capture higher rebates if locations have different product preferences). Revisit your program choice annually: rebate rates, volume thresholds, and competitive offers change. Request rate reviews from your account managers; loyalty programs are negotiable, especially for practices with $250K+ annual spend or multi-location footprints.